ARMP
Armata Pharmaceuticals Inc
NYSE MKT: ARMP · HEALTHCARE · BIOTECHNOLOGY
$9.87
+3.35% today
Updated 2026-04-30
Market cap
$366.22M
P/E ratio
—
P/S ratio
74.68x
EPS (TTM)
$-4.80
Dividend yield
—
52W range
$1 – $15
Volume
0.1M
Armata Pharmaceuticals Inc (ARMP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-775.00%
ROE
-3,439.00%
ROA
-23.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2005 | $6.87M | $-19.20M | 100.00% | -281.45% | -279.28% |
| 2006 | $9.86M | $-33.99M | 100.00% | -372.35% | -344.59% |
| 2007 | $10.33M | $-16.13M | 100.00% | -160.22% | -156.09% |
| 2008 | $8.72M | $-20.72M | 100.00% | -242.80% | -237.67% |
| 2009 | $12.17M | $7.95M | — | 13.89% | 65.30% |
| 2011 | $120000.00 | $-3.79M | — | -3,258.33% | -3,158.33% |
| 2012 | $664000.00 | $-1.11M | 100.00% | -606.02% | -167.17% |
| 2013 | $325000.00 | $-64.58M | 74.77% | -4,611.08% | -19,871.69% |
| 2014 | $409000.00 | $23.11M | 100.00% | -3,449.88% | 5,650.12% |
| 2015 | $475000.00 | $-516000.00 | 100.00% | -2,153.05% | -108.63% |
| 2016 | $260000.00 | $-18.84M | -41.92% | -8,991.54% | -7,245.38% |
| 2017 | $115000.00 | $-12.84M | -225.22% | -14,048.70% | -11,163.48% |
| 2018 | $0.00 | $-12.11M | — | — | — |
| 2019 | $31000.00 | $-19.48M | -4,358.06% | -61,577.42% | -62,835.48% |
| 2020 | $823000.00 | $-22.18M | -1,655.04% | -2,622.96% | -2,695.14% |
| 2021 | $4.47M | $-23.16M | -347.36% | -532.45% | -517.55% |
| 2022 | $5.51M | $-36.92M | -535.75% | -670.77% | -670.24% |
| 2023 | $4.53M | $-69.05M | 78.54% | -902.85% | -1,524.51% |
| 2024 | $5.17M | $-18.92M | -565.37% | -820.18% | -365.60% |
| 2025 | $4.90M | $-173.80M | 68.78% | -636.66% | -3,544.03% |